← Leaderboards
Kathryn L Terry
Brigham And Women'S Hospital
$5,529,062
Attributed
$6,744,350
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,744,350 · 5
By mechanism
R01$6,488,365 · 3
R21$179,000 · 1
R03$76,985 · 1
Top collaborators
- Sawsan As-Sanie3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Rulla M Tamimi$15,389,173
- David John Hunter$28,422,931
- Stacey Ann Missmer$8,921,131
- Alison J. Quayle$3,973,361
- Elizabeth A Stewart$4,734,535
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanParticipantCohortWomen&AposS HealthPathway InteractionsCancer RiskBiologicalProspectivePathogenesisMalignant Neoplasm Of OvaryTissuesOvarianRaceCase ControlInnovationLinkRisk FactorsNew EnglandBloodSamplingBiological MarkersQuestionnairesPrognostic Marker
Grant awards (14)
Novel biomarkers and pathways of persistent endometriosis-associated pain across the life course$807,304
R01 · FY2025 · HD
Changing Contraceptive Patterns and Ovarian Cancer Risk$391,252
R01 · FY2025 · CA · contact PI
Novel biomarkers and pathways of persistent endometriosis-associated pain across the life course$794,792
R01 · FY2024 · HD
Changing Contraceptive Patterns and Ovarian Cancer Risk$471,307
R01 · FY2024 · CA · contact PI
Novel biomarkers and pathways of persistent endometriosis-associated pain across the life course$828,480
R01 · FY2023 · HD
Changing Contraceptive Patterns and Ovarian Cancer Risk$535,417
R01 · FY2023 · CA · contact PI
Metabolomic profiling of adolescent endometriosis$179,000
R21 · FY2023 · HD · contact PI
Changing Contraceptive Patterns and Ovarian Cancer Risk$566,293
R01 · FY2022 · CA · contact PI
Changing Contraceptive Patterns and Ovarian Cancer Risk$528,213
R01 · FY2021 · CA · contact PI
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening$360,553
R01 · FY2019 · CA · contact PI
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening$371,704
R01 · FY2018 · CA · contact PI
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening$394,683
R01 · FY2017 · CA · contact PI
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening$438,367
R01 · FY2016 · CA · contact PI
Genetic Variants of Hormone Receptors in Ovarian Cancer$76,985
R03 · FY2003 · CA